about
Bone turnover during high dose inhaled corticosteroid treatmentA large volume spacer significantly reduces the effect of inhaled steroids on bone formationBone mass in patients with rheumatoid arthritis.The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary careAmenorrhoea in women with non-alcoholic chronic liver diseaseBone disease after liver transplantation.Systemic corticosteroid therapy--side effects and their management.Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.Renal transplantation and osteoporosis.Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in miceNutrition support in inflammatory bowel disease.Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.IL-6 Contributes to the Defective Osteogenesis of Bone Marrow Stromal Cells from the Vertebral Body of the Glucocorticoid-Induced Osteoporotic Mouse.Corticosteroids and osteoporosisBone turnover during short course prednisolone treatment in patients with chronic obstructive airways diseaseEffect of orally administered beclomethasone dipropionate on calcium absorption from the gut in normal subjectsEffects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study GroupPrevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study.Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndromeBone involvement in exogenous hypercortisolism.Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on boneChanges in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial.Efficacy and safety of inhaled corticosteroids. New developments.Beclomethasone and osteocalcin.Parathyroid hormone secretion in chronic human endogenous hypercortisolism.Effects of high doses of corticosteroids on bone metabolism.Psychological stress in people with profound mental retardation.Bone mineral density and body composition in patients with airflow obstruction--the role of inhaled steroid therapy, disease and lifestyle.Association of residual ridge resorption with systemic factors in home-living elderly subjects.
P2860
Q28316066-7598421E-43C2-4306-A546-8ED790E6A001Q28368114-A73923AA-0D0B-4034-A445-B513B8CCD124Q33564801-34FDDC61-3613-4380-B7A9-7E414D74AFDFQ33710863-F89BA713-58C1-4734-A76F-6A6A5127D5F4Q33775476-B0E9DC4C-988E-4127-BF37-3D4EDECC1DA3Q34393435-1FF9C8EE-4547-4406-ABEA-3E89373628F9Q34410041-969743AC-355F-4671-905E-D5E82CF6B655Q34478085-46BD443D-27D9-40F7-88EF-B6F33A584152Q34790932-9906439A-8DB7-4B2D-9E66-499293B0DB50Q34796211-BDF81BA9-B2C0-4E8D-AAA0-045EB8AE98DEQ35175707-F3715EF3-8C26-4B59-973F-117852C6CE53Q35209292-A20908E7-8723-401E-81B7-D4815670757DQ35601856-79D772A3-6B9F-46F8-99BF-BDE1A5947099Q35674916-B297E36F-4F32-4544-9784-8387B7D19681Q36003384-5C90183F-31FF-45F3-9901-428CABED2316Q36225071-2A1184C8-BE94-4953-A38D-3A58929D0982Q36263032-EE64988A-C73D-4B12-AA80-AE0F5A7FDB76Q36287161-DD4E51A1-5502-4E36-BC31-FFAA5D736ABCQ36571329-90BB9692-1B71-4DB1-B06D-2A90A84319E9Q36577487-9DCDF0F9-00C5-43E1-94EF-8C32D6B71338Q36599658-7DB99872-1BEB-46F8-8254-2886960C010CQ36680882-5328FE66-E10B-49B2-B321-05FABCD0E3DFQ37161922-2CF5A9A8-8504-4509-A70E-6A05B13428CAQ37383855-DE887EF3-8DB8-4704-B263-B8E9A5495B96Q39998140-EEF30D44-55BA-4589-9087-685191E68B9BQ41728966-1AE50040-EB97-4F6C-8943-29C5242C6808Q43164954-9E118F2C-FDF2-4D72-9EA3-34E1864DADD2Q43888285-E0ABA786-F264-45EC-8C53-E5AB3E4C7B93Q43944315-50005B93-5C6C-44C5-B987-C9F071DE1A44Q45247617-BB414FBF-67DC-416F-A9A4-D67F532B8EA3Q50863765-29E0E2A0-8FCB-4304-B7B3-50FE3DB33D3EQ50924219-8EB17494-5680-4CAB-AA31-686BF331F0E2
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Pathogenesis and treatment of steroid osteoporosis.
@en
type
label
Pathogenesis and treatment of steroid osteoporosis.
@en
prefLabel
Pathogenesis and treatment of steroid osteoporosis.
@en
P2860
P1476
Pathogenesis and treatment of steroid osteoporosis.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2265.1989.TB03730.X
P577
1989-01-01T00:00:00Z